The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of BMI on survival and toxicity in early breast cancer: An exploratory analysis of prospective randomized phase III study N-SAS BC02 and 03.
 
Yoichi Naito
Honoraria - AstraZeneca; Chugai Pharma; CI works; Eisai; Fujifilm; Merck Serono; Micron; Novartis; Ono Pharmaceutical; Sanofi; Taiho Pharmaceutical; Takeda
 
Yasuo Ohashi
No Relationships to Disclose
 
Isao Yokota
No Relationships to Disclose
 
Toru Watanabe
Honoraria - AstraZeneca; Chemifa; Chugai Pharma; Daiichi Sankyo; Eisai; Genomic Health; Kyowa Hakko Kirin; Novartis; Pfizer; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Kowa; Taiho Pharmaceutical; Yakult Honsha
 
Hiroji Iwata
Honoraria - AstraZeneca; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Eisai; GlaxoSmithKline; Nippon kayaku; Novartis; Pfizer; Sanofi; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Daiichi Sankyo; Novartis
Research Funding - Bayer; Chugai Pharma; Daiichi Sankyo; GlaxoSmithKline; Nippon Kayaku; Novartis; Parexel; Pfizer
 
Shozo Ohsumi
No Relationships to Disclose
 
Shinji Ohno
No Relationships to Disclose
 
Yasuo Hozumi
Honoraria - Novartis; Taiho Pharmaceutical
Consulting or Advisory Role - Kowa
Research Funding - Chugai Pharma; Daiichi Sankyo; Nippon Kayaku; Parexel
 
Seiichiro Yamamoto
No Relationships to Disclose
 
Masato Takahashi
No Relationships to Disclose
 
Tomohiko Aihara
No Relationships to Disclose
 
Hirofumi Mukai
Honoraria - AstraZeneca; Boehringer Ingelheim; Chugai Pharma; Daiichi Sankyo; Eisai; Novartis; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Chugai Pharma; Daiichi Sankyo; Eisai; Nippon Kayaku; Novartis; Pfizer; Sanofi